Google
×
AllImagesVideosNews Maps Shopping Books
Search tools
Past month
  • Any time
  • Past hour
  • Past 24 hours
  • Past week
  • Past month
  • Past year
All results
Clear

KFA-115 - Drug Targets, Indications, Patents - Patsnap Synapse

synapse.patsnap.com › drug
Nov 9, 2024 · A Phase I, Open-label, Multi-center Study of KFA115 as a Single Agent and in Combination With Pembrolizumab in Patients With Select Advanced Cancers.